Syros Pharmaceuticals, Inc.
SYRS
Revenue
387.00k
▼-3.38M▼-89.71%
3 Months ChangeAssets
85.00M
▼-21.73M▼-20.36%
3 Months ChangeLiabilities
96.12M
▼-16.96M▼-15.00%
3 Months ChangeFree Cash Flow
-37.14M
▼-6.99M▼-23.19%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0000950170-24-119236
2024-09-05
Form 8-K
ID: 0001193125-24-213668
2024-08-12
Form 8-K
ID: 0001193125-24-198969
2024-07-31
Form 10-Q
ID: 0000950170-24-088224
2024-06-06
Form 8-K
ID: 0001193125-24-156118
2024-05-14
Form 10-Q
ID: 0000950170-24-059068
2024-01-08
Form 8-K
ID: 0001193125-24-003863
2023-12-19
Form 8-K
ID: 0001193125-23-298696
2023-12-06
Form 8-K
ID: 0001193125-23-289541
2023-11-14
Form 10-Q
ID: 0000950170-23-063340